ConductScience.org, home

Paper10124

Pharmacokinetics of oxprenolol in normal subjects.

Mason WD and 1 other. Clin Pharmacol Ther, 1976. Cited by 66 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics of oxprenolol in normal subjects. Papers, record 10124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10124

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of oxprenolol in normal subjects.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
4.32
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mason WDW D
2Winer NN

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OxprenololMajor topic
Administration, Oral
Adrenergic beta-Antagonists
Adult
Biological Availability
Blood Pressure
Female
Humans
Injections, Intravenous
Kinetics
Male
Physical Exertion
Pulse

Source PubMed

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
41,735,694Estimating Human Jejunal Effective Permeability Using Numerical Deconvolution of Oral Solution Concentration Data.Pharm Res2026https://conductscience.org/library/papers/41735694PubMed
41,199,105An automated pipeline to generate initial estimates for population Pharmacokinetic base models.J Pharmacokinet Pharmacodyn2025https://conductscience.org/library/papers/41199105PubMed
34,112,223Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.Crit Care2021https://conductscience.org/library/papers/34112223PubMed
17,372,687Mechanistic approaches to volume of distribution predictions: understanding the processes.Pharm Res2007https://conductscience.org/library/papers/17372687PubMed
9,725,478Relative bioavailability of different oral sustained release oxprenolol tablets.Eur J Drug Metab Pharmacokinet1998https://conductscience.org/library/papers/9725478PubMed
8,261,714Individual variation in first-pass metabolism.Clin Pharmacokinet1993https://conductscience.org/library/papers/8261714PubMed
7,398,733Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7398733PubMed
7,356,910Pharmacokinetics of acebutolol after intravenous bolus administration.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7356910PubMed
7,175,699Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man.J Pharmacokinet Biopharm1982https://conductscience.org/library/papers/7175699PubMed
7,023,516Right ventricular performance in essential hypertension after beta-blockade.Br Heart J1981https://conductscience.org/library/papers/7023516PubMed
6,832,204Initiation and maintenance of beta-blockade with intravenous oxprenolol.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6832204PubMed
6,487,485Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487485PubMed
6,362,950First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362950PubMed
6,150,103Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.J Pharmacokinet Biopharm1984https://conductscience.org/library/papers/6150103PubMed
6,120,714Relationship between plasma beta-adrenoceptor blocker concentration and pharmacodynamic activity.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6120714PubMed
4,005,132Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4005132PubMed
4,005,122Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4005122PubMed
4,005,119Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4005119PubMed
4,005,118Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4005118PubMed
4,005,117In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4005117PubMed

See all 36 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10124

GET https://conductscience.org/api/papers/v1/10124/cited_by?page=2